Evidence map›Paper›PMID 40672051›Full record

ArticleThe Lancet regional health. Europe2025

Quantifying diagnostic intervals and routes to diagnosis for children and young people with cancer in the UK (Childhood Cancer Diagnosis study, CCD): a population-based observational study.

Dhurgshaarna Shanmugavadivel, Jo-Fen Liu, Timothy A Ritzmann, Ashley Ball-Gamble, Angela Polanco, Neil Ranasinghe, Kavita Vedhara, Shalini Ojha, David Walker

Abstract read
In one paragraph

Article in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dhurgshaarna ShanmugavadivelLifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
Jo-Fen LiuCCLG: The Children & Young People's Cancer Association, Leicester, UK.
Timothy A RitzmannChildren's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Ashley Ball-GambleCCLG: The Children & Young People's Cancer Association, Leicester, UK.
Angela PolancoCCLG: The Children & Young People's Cancer Association, Leicester, UK.
Neil RanasingheCCLG: The Children & Young People's Cancer Association, Leicester, UK.
Kavita VedharaSchool of Psychology, Cardiff University, UK & School of Medicine, Keele University, UK.
Shalini OjhaLifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
David WalkerChildren's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Childhood cancer is a global disease burden, with early diagnosis a priority. We quantified diagnostic intervals and referral routes for children and young people (CYP 0-18 years) diagnosed with cancer in the UK. Methods: All CYP diagnosed between September 2020-March 2023 were eligible. Demographic, referral, and symptom data were collected prospectively. Patient interval (PI), diagnostic interval (DI), and total diagnostic interval (TDI) were calculated. Findings: 1957 CYP (mean age 7.4 years, 55% male, 78% white) participated. Median PI, DI, and TDI were 1.1 (IQR 0.1-4.0; range 0-164), 1.7 (IQR 0.4-5.9; range 0-310), and 4.6 weeks (IQR 2.0-11.4; range 0-310), respectively. Intervals were unaffected by sex, ethnicity or deprivation index (IMD). Median TDI was longest in 15-18 years (8.7 weeks, IQR 3.0-17.4) and bone tumours (12.6 weeks, IQR 6.6-23.4) and shortest in under ones (3.7 weeks, IQR 1.0-8.1) and renal tumours (2.3 weeks, IQR 0.9-5.0). 74% (n = 1438) had 1-3 pre-diagnostic healthcare contacts; 67% (n = 1312) presented emergently, with a median of 4.0 (range 0-26) symptoms. CYP with Langerhans Cell Histiocytosis were most likely to have ≥4 visits when compared with leukaemia (adjusted OR 7.48, 95% CI 3.54-15.82), followed by central nervous system, bone, and soft tissue tumours. Interpretation: This study highlights equal access to diagnosis for sex, ethnicity and IMD, but disparities for age and diagnostic groups. These data will inform professional and public health strategies and health policy to accelerate diagnosis for all. Funding: National Institute for Health and Social Care Research (NIHR) DRF-2018-11-ST2-055.

Indexed as

Childhood cancerGlobal healthPaediatric oncologyPublic health

Identifiers

PMID40672051
PMCPMC12266182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.